SOPHiA GENETICS Appoints Chief Medical Officer
14.02.2020
Share this article
New appointment at SOPHiA GENETICS to accelerate the execution of its Medical Strategy
On 13 February 2020, SOPHiA GENETICS, leader in Data-Driven Medicine, announced the appointment of Philippe Menu, MD-PhD, MBA, as Chief Medical Officer.
The arrival of Dr. Philippe Menu in the SOPHiA GENETICS team will enable the Swiss based company to expand its scope for new clinical-grade applications such as “new biomarkers to develop new therapies”, treatment and patient matching through clinical trials, and much more.